EPIX
Essa Pharma Inc

3,160
Mkt Cap
$9.52M
Volume
5.95M
52W High
$6.11
52W Low
$0.18
PE Ratio
-0.35
EPIX Fundamentals
Price
$0.2012
Prev Close
$0.205
Open
$0.20
50D MA
$0.5993
Beta
0.55
Avg. Volume
3.16M
EPS (Annual)
-$0.6446
P/B
0.08
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
ESSA Announces Completion of Arrangement with XenoTherapeutics
ESSA Announces Completion of Arrangement with XenoTherapeutics ESSA Announces Completion of Arrangement with XenoTherapeutics PR Newswire SOUTH SAN FRANCISCO, Calif., USA and VANCOUVER, BC, Canada...
PR Newswire·2mo ago
News Placeholder
More News
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain Officers - EPIX
INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against ESSA Pharma Inc. and Certain Officers - EPIX INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class...
PR Newswire·9mo ago
News Placeholder
Levi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - EPIX
Levi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - EPIX Levi & Korsinsky Notifies ESSA Pharma Inc. Investors of a Class Action Lawsuit and Upcoming...
PR Newswire·9mo ago
News Placeholder
Shareholders of ESSA Pharma Inc. Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - EPIX
Shareholders of ESSA Pharma Inc. Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - EPIX Shareholders of ESSA Pharma Inc. Should Contact The Gross Law Firm Before March...
PR Newswire·9mo ago
News Placeholder
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, Feb. 22, 2025...
PR Newswire·9mo ago
News Placeholder
ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX
ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX ESSA Pharma Inc. Class...
PR Newswire·9mo ago
News Placeholder
Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX
Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX Faruqi & Faruqi Reminds ESSA Pharma Investors of the Pending...
PR Newswire·9mo ago
News Placeholder
Investors who lost money on ESSA Pharma Inc.(EPIX) should contact The Gross Law Firm about pending Class Action - EPIX
Investors who lost money on ESSA Pharma Inc.(EPIX) should contact The Gross Law Firm about pending Class Action - EPIX Investors who lost money on ESSA Pharma Inc.(EPIX) should contact The Gross Law...
PR Newswire·9mo ago
News Placeholder
ESSA Pharma Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EPIX
ESSA Pharma Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - EPIX ESSA Pharma Inc. Sued for Securities Law Violations - Investors Should...
PR Newswire·9mo ago
News Placeholder
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit
EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit EPIX Investors Have Opportunity to Lead ESSA Pharma Inc. Securities Fraud Lawsuit PR Newswire NEW YORK, Feb. 16, 2025...
PR Newswire·10mo ago

Latest EPIX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.